The Bipartisan Commission on Biodefense urges policymakers to learn from the Covid-19 pandemic and address critical gaps in the nation’s biodefense. That needs to happen before we face the next infectious disease pandemic or biological attack.
- Asha George, executive director of the Bipartisan Commission on Biodefense, said biosecurity risks consist of naturally occurring disease, organisms accidentally released from labs and biological weapons.
- George said the Biden administration’s American Pandemic Preparedness plan drew from a report by her commission and focuses on development of medical countermeasures, identification of emerging diseases and fast response.
- George said she thinks the country is not prepared for future pandemics and should plan as if one will occur on an annual basis.
- Because multiple agencies are involved, biodefense leadership should reside in the White House at a high level, said George.
- George said the U.S. should pay close attention to developments in bioterrorism threats from the Taliban.